Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

604 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, Schenck-Gustafsson K, Smith SC Jr, Taubert KA, Wenger NK; American Heart Association. Mosca L, et al. Among authors: wenger nk. Circulation. 2001 Jul 24;104(4):499-503. doi: 10.1161/hc2901.092200. Circulation. 2001. PMID: 11468217 No abstract available.
Cardiovascular disease in women.
Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Eaker ED, et al. Among authors: wenger nk. Circulation. 1993 Oct;88(4 Pt 1):1999-2009. doi: 10.1161/01.cir.88.4.1999. Circulation. 1993. PMID: 8403349 Review. No abstract available.
Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).
Herrington DM, Fong J, Sempos CT, Black DM, Schrott HG, Rautaharju P, Bachorik PS, Blumenthal R, Khan S, Wenger NK. Herrington DM, et al. Among authors: wenger nk. Am Heart J. 1998 Jul;136(1):115-24. doi: 10.1016/s0002-8703(98)70191-7. Am Heart J. 1998. PMID: 9665228 Clinical Trial.
Coronary heart disease in women, randomized clinical trials, HERS and RUTH.
Barrett-Connor E, Wenger NK, Grady D, Mosca L, Collins P, Kornitzer M, Cox DA, Moscarelli E, Anderson PW. Barrett-Connor E, et al. Among authors: wenger nk. Maturitas. 1998 Nov 30;31(1):1-7. doi: 10.1016/s0378-5122(98)00099-1. Maturitas. 1998. PMID: 10091198 No abstract available.
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II.
Smith SC Jr, Amsterdam E, Balady GJ, Bonow RO, Fletcher GF, Froelicher V, Heath G, Limacher MC, Maddahi J, Pryor D, Redberg RF, Roccella E, Ryan T, Smaha L, Wenger NK. Smith SC Jr, et al. Among authors: wenger nk. Circulation. 2000 Jan 4;101(1):E12-6. doi: 10.1161/01.cir.101.1.e12. Circulation. 2000. PMID: 10618317 No abstract available.
Design and methods of the Raloxifene Use for The Heart (RUTH) study.
Mosca L, Barrett-Connor E, Wenger NK, Collins P, Grady D, Kornitzer M, Moscarelli E, Paul S, Wright TJ, Helterbrand JD, Anderson PW. Mosca L, et al. Among authors: wenger nk. Am J Cardiol. 2001 Aug 15;88(4):392-5. doi: 10.1016/s0002-9149(01)01685-x. Am J Cardiol. 2001. PMID: 11545760
Evidence-based guidelines for cardiovascular disease prevention in women.
Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC Jr, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL; American Heart Association. Mosca L, et al. Among authors: wenger nk. Circulation. 2004 Feb 10;109(5):672-93. doi: 10.1161/01.CIR.0000114834.85476.81. Epub 2004 Feb 4. Circulation. 2004. PMID: 14761900 Free article. No abstract available.
604 results